Search research articles
Contact Us
Filters
Showing results (1-10 of 281) with videos related to
Page
of 29
Sort By:
Best Practice & Research. Clinical Gastroenterology
|
December 3, 2017
Alcohol, smoking and the liver disease patient
Hannes Hagström
Current Hepatology Reports
|
July 15, 2017
Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?
Hannes Hagström
Scandinavian Journal of Gastroenterology
|
May 15, 2025
Fishing for proteomic signatures for fibrosis in MASLD - what's in the net?
Hannes Hagström
Hepatology (Baltimore, Md.)
|
May 1, 2022
A new model for estimation of significant fibrosis in primary care. SAFE to use?
Hannes Hagström
Alimentary Pharmacology & Therapeutics
|
May 20, 2020
Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD?
Hannes Hagström
Lakartidningen
|
March 16, 2016
[Infections common in acute and chronic liver disease]
Hannes Hagström, Fredrik Rorsman
Journal of Internal Medicine
|
April 4, 2022
Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study
Axel Wester, Hannes Hagström
Hepatology (Baltimore, Md.)
|
July 9, 2022
Less is more? Screening for steatosis in older populations
Hannes Hagström, Ying Shang
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 18, 2022
Reply
Axel Wester, Hannes Hagström
United European Gastroenterology Journal
|
October 19, 2023
Challenges with neuropsychiatric Wilson's disease
Fredrik Åberg, Hannes Hagström
Page
of 29
Search research articles
Search
Showing results (1-10 of 281) with videos related to
Sort By:
Page
of 29
Best Practice & Research. Clinical Gastroenterology
|
December 3, 2017
Alcohol, smoking and the liver disease patient
Hannes Hagström
Current Hepatology Reports
|
July 15, 2017
Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?
Hannes Hagström
Scandinavian Journal of Gastroenterology
|
May 15, 2025
Fishing for proteomic signatures for fibrosis in MASLD - what's in the net?
Hannes Hagström
Hepatology (Baltimore, Md.)
|
May 1, 2022
A new model for estimation of significant fibrosis in primary care. SAFE to use?
Hannes Hagström
Alimentary Pharmacology & Therapeutics
|
May 20, 2020
Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD?
Hannes Hagström
Lakartidningen
|
March 16, 2016
[Infections common in acute and chronic liver disease]
Hannes Hagström, Fredrik Rorsman
Journal of Internal Medicine
|
April 4, 2022
Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study
Axel Wester, Hannes Hagström
Hepatology (Baltimore, Md.)
|
July 9, 2022
Less is more? Screening for steatosis in older populations
Hannes Hagström, Ying Shang
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 18, 2022
Reply
Axel Wester, Hannes Hagström
United European Gastroenterology Journal
|
October 19, 2023
Challenges with neuropsychiatric Wilson's disease
Fredrik Åberg, Hannes Hagström
Page
of 29